MEPRIMET MV1 TABLET

Product Description

MEPRIMET MV1 TABLET is a triple-action oral antidiabetic formulation combining Glimepiride 1mg, Metformin 500mg, and Voglibose 0.2mgdesigned to deliver comprehensive glycemic control in patients with Type 2 Diabetes Mellitus. Manufactured under WHO-GMP certified facilities, this formulation is ideal for clinicians, pharmacies, and bulk medicine suppliers seeking a trusted and effective anti-diabetic solution.A preferred choice in diabetes management, MEPRIMET MV1 targets insulin resistance, postprandial glucose spikes, and beta-cell dysfunction, offering improved patient adherence with a single, convenient tablet.Key Benefits: Triple drug combination for holistic blood sugar control Reduces fasting and post-meal blood glucose levels effectively Manufactured with pharma-grade raw materials ensuring purity and potency Ideal for bulk procurement by distributors, hospitals, and pharmacy chains Indications: Type 2 Diabetes Mellitus (T2DM) Insulin-resistant and postprandial hyperglycemia cases Suitable as first-line or combination therapy Why Choose MEPRIMET MV1 TABLET? Clinically validated combination therapy High demand among diabetologists and general practitioners Competitive pricing for bulk buyers and B2B resellers Ready-to-ship stock for pan-India delivery